Open access · CC-BY
via OpenAlex
Kidney Fibrosis and Matrix Metalloproteinases (MMPs)
Antonella La Russa, Raffaele Serra, Teresa Faga, Giuseppina Crugliano, Angelica Bonelli, Giuseppe Coppolino, Davide Bolignano, Yuri Battaglia, Nicola Ielapi, Davide Costa, Ashour Michael, Michele Andreucci
Frontiers in Bioscience-Landmark · 2024 · ▲ 36 citations
Abstract
Chronic kidney disease (CKD) is a disorder that causes changes in both the structure and function of the kidneys, causing complications such as hypertension, edema, and oliguria. Renal fibrosis is also a common pathological feature of CKD. Matrix metalloproteinases (MMPs) are endopeptidases that degrade extracellular matrix (ECM) proteins. The proteinase domain consists of a zinc ion in the active site, which contributes to its stabilization with another zinc and three calcium structural ions. Many cellular processes are controlled by MMPs, such as cell-cell interactions and various signaling pathways, while they are also involved in degrading substrates on cell surfaces. Tissue inhibitors of metalloproteinases (TIMPs) are key regulators of metalloproteinases, and both are involved in regulating cell turnover, the regulation, and the progression of fibrosis and apoptosis in the tissue. MMPs play a role in renal fibrosis, such as the tubular cell epithelial-mesenchymal transition (TEM), activation of resident fibroblasts, endothelial-mesenchymal transition (EndoMT), and pericyte-myofibroblast transdifferentiation. This review aims to show the mechanisms through which MMPs contribute to renal fibrosis, paying particular attention to MMP-9 and the epithelial-mesenchymal transition.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.31083/j.fbl2905192
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Russa, A.L., Serra, R., Faga, T., Crugliano, G., Bonelli, A., Coppolino, G., Bolignano, D., Battaglia, Y., Ielapi, N., Costa, D., Michael, A., & Andreucci, M. (2024). Kidney Fibrosis and Matrix Metalloproteinases (MMPs). <em>Frontiers in Bioscience-Landmark</em>. https://doi.org/10.31083/j.fbl2905192
Vancouver
Russa AL, Serra R, Faga T, Crugliano G, Bonelli A, Coppolino G, et al. Kidney Fibrosis and Matrix Metalloproteinases (MMPs). Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2905192.
BibTeX
@article{antonella2024Kidney,
title = {Kidney Fibrosis and Matrix Metalloproteinases (MMPs)},
author = {Antonella La Russa and Raffaele Serra and Teresa Faga and Giuseppina Crugliano and Angelica Bonelli and Giuseppe Coppolino and Davide Bolignano and Yuri Battaglia and Nicola Ielapi and Davide Costa and Ashour Michael and Michele Andreucci},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2905192},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Research at the University of Copenhagen (University of Copenhagen) 2026
Preprint · OA
Extracellular matrix biomarkers for hepatic fibrosis and disease endotyping
Frontiers in Bioscience-Scholar 2009
Citation only
CTGF and chronic kidney fibrosis
Journal of Crohn s and Colitis 2023
Open access · CC-BY
Matrix metalloproteinases in intestinal fibrosis
Cold Spring Harbor Perspectives in Biology 2011
Preprint · OA
Extracellular Matrix Degradation and Remodeling in Development and Disease
Matrix Biology 2017
Open access · CC-BY
Matrix metalloproteinases and liver fibrosis (translational aspects)
Current Tissue Microenvironment Reports 2021
Open access · CC-BY